Study Stopped
The planned 15-month recruitment period was completed.
Nonarthritic Hip Disease Evaluation And Treatment
NEAT
Informed Decisions and Patient Outcomes: An Interdisciplinary Approach to Chronic Hip Pain
1 other identifier
interventional
112
1 country
1
Brief Summary
The investigators aim to understand how interdisciplinary care influences decisions, expectations, and outcomes for patients with non-arthritic hip disease (NAHD). Patients presenting to the Ohio State University Wexner Medical Center (OSUWMC) Hip Preservation Clinic will be approached for participation. All participants will proceed with their scheduled, standard-care physician evaluation. Participants without NAHD will be excluded. Participants will then be randomized to receive a same-day physical therapist (PT) evaluation. This PT evaluation is not a standard-care practice in the clinic, this was added for research. All participants will complete expectation surveys before and after their evaluation(s). The clinicians will discuss their recommended plan with the patient and the patient will record a final treatment decision and outcome expectations. Participants will then be randomized to either receive posture and movement training (PMT) for 3 weeks or undergo a 3-week wait period. All participants will be required to withhold any treatment during this 3-week period (except PMT in the PMT group). The 3-week wait period for the no-PMT group is aligned with current clinical processes for time from physician evaluation to start of treatment. All participants may proceed with any further interventions (including PMT) after the 3-week period, but none will be provided/required as part of research. Patient-reported outcomes and clinical tests will be recorded before and after the 3-week period, and 3 and 6 months later. Adding a PT evaluation to the physician visit provides no additional risk because the PT evaluation includes similar clinical tests to the physician and movement analysis during tasks participants complete during daily life. Clinical tests before/after the 3-week intervention period may produce muscle soreness that should resolve within 2 days. Understanding how interdisciplinary care influences expectations and outcomes can inform clinicians regarding the effectiveness of interdisciplinary collaboration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2018
CompletedFirst Submitted
Initial submission to the registry
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedResults Posted
Study results publicly available
May 6, 2020
CompletedMay 6, 2020
May 1, 2020
1.3 years
March 27, 2018
October 8, 2019
May 5, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Treatment Plan
Participants will indicate their planned treatment(s)
Post-evaluation, same-day (approximately 5-10min after evaluation)
Decisional Conflict
Participants will report decisional conflict related to their treatment plan. Decisional conflict was measured using the Decisional Conflict Scale ranging from 0 (no conflict, better outcome) to 100 (high conflict, worse outcome).
Pre-evaluation, 10min Post-evaluation
Secondary Outcomes (5)
Themes From Provider Interviews
Pre-enrollment (2-7days before patient participant recruitment began), Post-enrollment (1-7 days after patient participant recruitment ended)
Participant Protocol Opinions
20min post-evaluation, 4 weeks post-evaluation
Decisional Conflict
10min post-evaluation, 4-week laboratory visit
Patient-reported Hip Function
10min post-evaluation, 4-week laboratory visit
Movement Mechanics
Baseline laboratory visit, 4-week laboratory visit
Other Outcomes (3)
Decisional Regret
Day of enrollment, after all evaluations are complete
Decisional Regret
4 weeks
Changes in Hip Strength
4 weeks
Study Arms (5)
Interdisciplinary Evaluation
EXPERIMENTALParticipants will receive an Interdisciplinary Evaluation for Nonarthritic Hip Disease from a hip arthroscopist, followed by an examination from a physical therapist, and then will participate in a shared decision-making process with both providers to determine a plan of care.
Standard Evaluation
NO INTERVENTIONParticipants will receive a standard-of-care evaluation from a hip arthroscopist who will then determine the plan of care with the participant.
Posture and Movement Training
EXPERIMENTALParticipants will receive six training sessions with a physical therapist over a 3-week period.
3-week Wait Period
NO INTERVENTIONParticipants will undergo a 3-week wait period. They will be instructed to not receive any treatment (e.g. chiropractic services, physical therapy, medication, surgery, injections) for their hip symptoms during this time.
Observational Arm
OTHERParticipants who refuse randomization to receive posture and movement training may continue participation in an observational group. These participants complete the same baseline and follow-up testing but proceed with their treatment-of-choice during the 3-week intervention period.
Interventions
The hip arthroscopist will conduct his or her standard-care evaluation including subjective interview, patient history, imaging, and physical examination. The physical therapist will conduct an assessment of posture and movement during sitting, standing, squatting, and walking. After providers discuss their findings, they will discuss the plan of care with the participant.
Physical therapists will lead participants through an intervention protocol to normalize seated and standing posture and function movement. Verbal, visual, and tactile cues, along with strengthening exercises will be provided to train posture and movement.
Participants may proceed with any treatment-of-choice, which may or may not have been recommended by their health care provider(s). Treatments will be recorded, but not controlled.
Eligibility Criteria
You may qualify if:
- Over 18 years old NAHD diagnosis
You may not qualify if:
- Osteoporosis or rheumatoid arthritis
- Systemic health condition
- Legal representative required for treatment decisions
- Bilateral symptoms
- Current spine, hip, knee, or ankle surgery or major injury\*
- Pregnancy
- Total hip arthroplasty candidate (Tönnis grade \> 2)
- Periacetabular osteotomy candidate (lateral center edge angle\<20, anterior center edge angle\<18, acetabular index \>10)
- Participants with history of spine, hip, knee, or ankle surgery or major injury will be evaluated by the physician to determine appropriateness for evaluation (and treatment) by a physical therapist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- Foundation for Physical Therapy, Inc.collaborator
- Washington University School of Medicinecollaborator
Study Sites (1)
The Ohio State University Wexner Medical Center Jameson Crane Sports Medicine Institute
Columbus, Ohio, 43202, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Seventy-eight (78) participants were included from the 15-month recruitment period (81% of the target n=96). Randomization for interdisciplinary vs. standard evaluation had to occur before physician evaluation, modified from the original protocol.
Results Point of Contact
- Title
- Dr. Stephanie Di Stasi
- Organization
- The Ohio State University
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Di Stasi, PhD, PT
Ohio State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 27, 2018
First Posted
May 8, 2018
Study Start
February 27, 2018
Primary Completion
May 31, 2019
Study Completion
May 31, 2019
Last Updated
May 6, 2020
Results First Posted
May 6, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
At this time, our IPD will be shared with researchers listed on the funding mechanisms for this project. When submitting manuscripts, IPD will be available upon request.